Diagnostic Imaging of Emerging Infectious Diseases

Name: Diagnostic Imaging of Emerging Infectious Diseases
SKU: 978-94-024-1335-9
Price: 178.00 CHF
Availability: InStock

Artikelnummer: 978-94-024-1335-9

Einband: Kartonierter Einband (Kt)

Verfügbarkeit: POD-Titel lieferbar in 5 bis 10 Arbeitstagen

CHF 178.00

Menge: decrease increase

This book introduces the diagnosis of Emerging Infectious Diseases (EIDs), including newly emerging infectious diseases and also infectious diseases that show resistance to present treatments. Radiographic examinations are of great value in EIDs diagnosis, differential diagnosis, treatment efficacy assessment and prognosis evaluation. This book covers severe acute respiratory syndrome (SARS), human avian influenza (H5N1, H7N9), influenza A (H1N1), hand-foot-mouth disease, acquired immune deficiency syndrome (AIDS), viral hepatitis, pulmonary tuberculosis. All seven of these EIDs are associated with high incidence and mortality. This book details the imaging techniques, radiological appearance and characteristics of EIDs, and diagnosis and differential diagnosis of EID-related complications. Considering the unique and in some cases only partially understood nature of EIDs, appropriate space is provided in this book for the detailed explanation of the etiology, epidemiology, pathophysiology, clinical symptoms and signs, laboratory tests, clinical diagnosis and differential diagnosis, prevention, treatment, and prognosis of EIDs. As such, it will be a valuable resource for improving the prevention, diagnosis, and treatment of EIDs.

Editors Pu-Xuan Lu and Bo-Ping Zhou are professors at Shenzhen Third People's Hospital, Guangdong Medical College, China.

"The book will be an invaluable aid for infectious disease experts and radiologists interested in the field. The production is of the usual high standard set by Springer. The editors and contributors from China deserve to be congratulated in putting a book like this together. It showcases their vast experience of these diseases and we in the West will benefit from their knowledge by reading this scholarly contribution to an important field of medicine." (Dr. Arpan K. Banerjee, RAD Magazine, November, 2016)

EUDR exemption - product or manufacturing materials placed on the market prior to 31.12.2025.

Beschrieb
Bewertungen
Anfrage zu diesem Produkt

Editors Pu-Xuan Lu and Bo-Ping Zhou are professors at Shenzhen Third People's Hospital, Guangdong Medical College, China.

EUDR exemption - product or manufacturing materials placed on the market prior to 31.12.2025.

Schreiben Sie Ihre eigene Bewertung

Nur registrierte Benutzer können Produkte bewerten

Ihr Name *

Ihre E-Mail *

Betreff: *

Anfrage *

Verlag	Springer EN
Einband	Kartonierter Einband (Kt)
Erscheinungsjahr	2019
Seitenangabe	228 S.
Ausgabekennzeichen	Englisch
Abbildungen	XV, 213 p. 100 illus., 47 illus. in color., schwarz-weiss Illustrationen, farbige Illustrationen
Masse	H27.9 cm x B21.0 cm 828 g
Coverlag	Springer (Imprint/Brand)
Auflage	Softcover reprint of the origi
Autor	Lu, Pu-Xuan (Hrsg.) / Zhou, Bo-Ping (Hrsg.)

Über den Autor Pu-Xuan (Hrsg.) Lu

Pu-Xuan Lu is a Chief Medical Specialist of Shenzhen Center for Chronic Disease Control,Shenzhen Institute of Pulmonology ; first-level chief physician of The Third People's Hospital of Shenzhen ; a professor and graduate supervisor of Guangdong Medical University. His research fields include diagnostic imaging and differential diagnosis of emerging infectious diseases, such as SARS, MERS, AIDS, human infected avian influenza, tuberculosis, hepatitis, and other infectious diseases as well as clinical and basic sciences of emerging infectious diseases. Professor Lu has edited or co-edited more than 20 academic treatise. Diagnostic Imaging of Emerging Infectious Diseases has been published by Springer in November 2015, which obtained national key award for book output in May 2017 by the General Administration of News and Publishing, China.In 2020, he co-edited Tuberculosis Control in Migrating Population in Springer, and won the third Springer Nature: China New Development Award in September 2021. Hongzhou Lu, M.D., Ph.D., the director of Shenzhen Third People's Hospital, a world-renowned scholar of infectious diseases, World's Top 2% Scientists in 2021 (Stanford University), winner of the Charpak Dubousset Prize of the French National Academy of Medicine, fellow of the American Academy of Microbiology Prof. Lu has long been dedicated to the basic research and clinical practice of infectious diseases. During the influenza A (H1N1, H7N9) and COVID-19 pandemics, he led the early treatment efforts and pioneered clinical and basic research on related diseases in Shanghai, making essential contributions to the prevention of disease epidemics in China. Professor Lu's work has been supported by the Bill & Melinda Gates Foundation, and the National Institutes of Health. He has published more than 500 research papers in international journals, including Nature, New England Journal of Medicine, and Cell Research et al. Yong-xiang Yi, MD, Vice President of Nanjing Drum Tower Hospital. Distinguish Professor, Ph.D Supervisor of Nanjing University of Chinese medicine. National Excellent Hospital President. Experts rewarded special government allowances from the State Council. Vice Chairman of Infectious Disease Hospital of China Hospital Association.Vice Chairman of the Liver Disease Committee of the Chinese Association of Research Hospitals and Leader of the Liver Cancer Group. Chairman of infectious disease hospital of Jiangsu Hospital Association. Chairman of the Infectious Diseases of Jiangsu Association of Traditional Chinese Medicine. He has been engaged in general surgery for more than 30 years, and has long been committed to the research of various complicate liver disease, gallbladder and pancreatic tumors, intestinal microbiota. He has conducted multiple national, provincial and municipal scientific research projects, published more than 60 SCI papers, written 7 professional books, and published 2 international patents.